top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advance in the Treatment of Pediatric Leukemia
Advance in the Treatment of Pediatric Leukemia
Autore Handgretinger Rupert
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (300 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato acute lymphoblastic leukemia
pediatric
advances
diagnosis
treatment
immunotherapy
bispecific T-cell engager (BiTE)
BCP-ALL
leukemia
TRAIL
antibody
Fc-engineering
xenograft
CD19
juvenile myelomonocytic leukemia
RAS signaling
hematopoietic stem cell transplantation
5-azacitidine
myelodysplastic/myeloproliferative disorders
targeted therapy
ADC
antibody-drug conjugate
pediatric leukemia
ALL
AML
allogeneic stem cell transplantation
acute myeloid leukemia
minimal residual disease
conditioning regimen
alternative donors
B-ALL
DUX4
IKZF1
PAX5
Ph-like
ZNF384
NUTM1
T-ALL
NOTCH1
BCL11B
transcriptome
genome
chronic myeloid leukemia
CML
tyrosine kinase inhibitor
immunizations
COVID-19
childhood acute lymphoblastic leukemia
low-risk ALL
risk-stratified treatment
treatment related toxicity
L-asparaginase
acute pancreatitis
polymorphism
SNV
ABCC4
CFTR
other extramedullary relapse
lymphoblastic leukemia
children
prognosis
evolution of CAR T cells
FDA-approved CAR products
TcR versus CAR
limitations and complications of CAR T cell therapy
future directions of CAR T cell therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576878903321
Handgretinger Rupert  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Autore Griffioen Marieke
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (139 p.)
Soggetto topico Medicine
Immunology
Soggetto non controllato minor histocompatibility antigens
neoantigens
hematological malignancies
allogeneic stem cell transplantation
immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557776503321
Griffioen Marieke  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui